AII
TARO

AGF Investments Inc’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

AGF Investments Inc’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-204
Closed -$24K – 484
2017
Q1 		$24K Buy
+204
New +$22.6K ﹤0.01% 427

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AGF Investments Inc's TARO Position: Q2 2017 in Review

AGF Investments Inc sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2017, closing a stake of 204 shares — an estimated $24K sold.

AGF Investments Inc first reported a position in TARO in Q1 2017 and held it in 1 quarter. The position peaked at $24K in Q1 2017. 140 funds tracked by Wall St. Rank hold TARO as of Q2 2017.

  • AGF Investments Inc reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2017 after selling out during the quarter.
  • AGF Investments Inc sold 204 Taro Pharmaceutical Industries Ltd. shares in Q2 2017, an estimated $24K.
  • AGF Investments Inc first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2017 and held it in 1 quarter.
  • AGF Investments Inc's Taro Pharmaceutical Industries Ltd. position peaked at $24K in Q1 2017.
  • 140 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2017.

Based on AGF Investments Inc's 13F filing for Q2 2017, filed 10 Aug 2017.